Dr. Juan Pablo Alderuccio, MD
- Medicare services, 2024
- 266
- Medicare patients, 2024
- 105
- Part D claims, 2024
- 298
- Publications
- 72
- Clinical trials
- 3
- Practice address
- 1475 Nw 12th Ave, Miami, FL 33136
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Alderuccio's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Juan Pablo Alderuccio is a hematologist and oncologist in Miami, Florida
Dr. Alderuccio practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.
Dr. Alderuccio's NPI, 1639502123, was assigned on August 20, 2013. Dr. Alderuccio holds Florida license ME131937.
- NPI
- 1639502123NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0143588343
- NPI enumeration date
- August 20, 2013
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 49
- Medical school graduation
- 2003
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Juan Pablo Alderuccio practices at Sylvester Comprehensive Cancer Center in Miami, Florida
Dr. Alderuccio's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.
- Sylvester Comprehensive Cancer Center1475 Nw 12th Ave, Miami, FL 33136
Source: Dmand AI Affiliation Data
Dr. Juan Pablo Alderuccio is affiliated with 2 sites of care and 1 medical group
Dr. Alderuccio's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Alderuccio is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Juan Pablo Alderuccio's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alderuccio practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Sylvester Comprehensive Cancer Center | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Miami and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Juan Pablo Alderuccio is one of 693 hematologists and oncologists in Florida
Hematology and oncology is Dr. Alderuccio's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Alderuccio is board certified in hematology by the American Board of Internal Medicine. Dr. Alderuccio is licensed in Florida.
Specialties and state licenses
- Hematology and oncology, FloridaPrimary
Hematologists and oncologists near Dr. Alderuccio
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Juan Pablo Alderuccio billed Medicare for 266 services in 2024
CMS data shows 266 Medicare services from Dr. Alderuccio across 5 procedure codes in 2024, for 105 Medicare patients. Medicare paid $23,863 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Alderuccio's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3232024: 26618%
Dr. Alderuccio compared with the Florida median for hematologists and oncologists, 2024
- Dr. Alderuccio
- Florida median
- Medicare services
- 266vs 69762% below
- Medicare patients
- 105vs 21852% below
- Part D claims
- 238vs 34130% below
Medians across 638 hematologists and oncologists in Florida with Dmand AI profiles that report each measure.
Dr. Alderuccio's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Alderuccio?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Alderuccio and other hematologists and oncologists in Florida.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Juan Pablo Alderuccio treated 105 Medicare patients in 2024, average age 73
CMS counts 105 Medicare patients who saw Dr. Alderuccio in 2024. The largest group is 75 to 84, with 50 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 23% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Alderuccio's median patient age at 72, with 53% women.
Dr. Alderuccio's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Alderuccio's Medicare patients by sex, 2024
- Women4442%
- Men6158%
Chronic conditions among Dr. Alderuccio's Medicare patients, 2024
- High cholesterol75%
- High blood pressure71%
- Chronic kidney disease39%
- Arthritis38%
- Ischemic heart disease34%
- Diabetes31%
- Mood disorders30%
- Anxiety25%
Share of Medicare patients with each condition. A patient can have several.
Dr. Alderuccio's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women53%
- Men47%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Juan Pablo Alderuccio wrote 298 Medicare Part D claims in 2024
In 2024, Dr. Alderuccio wrote 298 Medicare Part D claims for 43 patients. 71% of them were for generic drugs. CMS names the drug for 238 of them, across 10 drugs with 11 or more claims each, at $1,283,221 in total drug cost. In 2023, CMS named 294 claims across 10 drugs.
Dr. Alderuccio's Part D claims by kind of drug, 2024
- Generic213 claims71%
- Brand-name85 claims29%
Dr. Alderuccio's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Alderuccio's Part D claims, 2024
- Antibiotics8%25 of 298 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2942024: 23819%
Drugs named by CMS: 10 in 2024, 10 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Juan Pablo Alderuccio scored 88 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Alderuccio for performance year 2024, reported as part of a group. Dr. Alderuccio accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alderuccio as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Alderuccio's MIPS scores, performance year 2024
- 88of 100Final score
- 78.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 71of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Juan Pablo Alderuccio has 72 publications on record
Dmand AI links 72 papers to Dr. Alderuccio, published from 2013 to 2025. 2021 was the busiest year, with 12. The most frequent topics are Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse and Antineoplastic Combined Chemotherapy Protocols. Dr. Alderuccio has published most often in Blood Adv. Dr. Alderuccio's most frequent co-authors are Izidore Lossos, MD, Paolo F. Caimi, MD and Brad Steven Kahl, MD.
Dr. Alderuccio's papers by year, 2016 to 2025
Topics Dr. Alderuccio writes about most
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Large B-Cell, Diffuse
- Antineoplastic Combined Chemotherapy Protocols
- Antibodies, Monoclonal, Humanized
- Benzodiazepines
- Lymphoma, Follicular
- Positron Emission Tomography Computed Tomography
- Cell Transformation, Neoplastic
Dr. Alderuccio's most frequent co-authors
- Izidore Lossos, MD49 shared papers
- Paolo F. Caimi, MD12 shared papers
- Brad Steven Kahl, MD12 shared papers
Recent publications by Dr. Alderuccio
See who Dr. Alderuccio researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Alderuccio works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Juan Pablo Alderuccio has worked on 3 clinical trials
Dmand AI links Dr. Alderuccio to 3 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Lymphoma, B-Cell, Marginal Zone, Lymphoma, Follicular and Lymphoma, Large B-Cell, Diffuse.
Clinical trials with Dr. Alderuccio by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 1Phase 2/3: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Alderuccio's trials
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
Investigators on the most trials with Dr. Alderuccio
- Jennifer Effie Amengual, MD1 shared trial
- Emily Case Ayers, MD1 shared trial
- Ashraf R. Aziz, MD1 shared trial
Recent clinical trials with Dr. Alderuccio
Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Juan Pablo Alderuccio received $50,498 in industry payments from 2016 to 2025
CMS Open Payments shows 321 general payments to Dr. Alderuccio from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. ADC Therapeutics America, Inc. paid the most, $14,679.
General payments to Dr. Alderuccio by program year, 2016 to 2025
General payments to Dr. Alderuccio by kind, 2016 to 2025
- Consulting fees$35,13270%
- Food and beverage$7,69315%
- Travel and lodging$4,80410%
- Honoraria$2,4005%
- Other$4691%
Companies that paid Dr. Alderuccio the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Juan Pablo Alderuccio has 3 awards and honors on record
Dmand AI lists 3 awards for Dr. Alderuccio, most recently Clinical Investigator Career Development Award in 2022. Dr. Alderuccio serves on Protocol Review and Monitoring Committee and American Society of Hematology Committee on Educational Affairs.
Awards and honors for Dr. Alderuccio
- 2022
- Clinical Investigator Career Development Award
- FDA-AACR Oncology Educational Fellowship
- 2021
- K12 Calabresi Clinical Oncology Research Career Development Award
Dr. Alderuccio's committees and leadership roles
- Protocol Review and Monitoring CommitteeMember
- 2021 to present
Source: Dmand AI Professional Profile Data
Dr. Juan Pablo Alderuccio is board certified in hematology
Dr. Alderuccio is a member of ASCO and ASH.
- Board certified in hematology
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Juan Pablo Alderuccio accepts plans from 10 insurance carriers
Dr. Alderuccio is in network with 10 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.
- Aetna
- Elevance
- United Healthcare
- Molina
- Aspirus Health Plan
- Blue Cross and Blue Shield of Kansas City
- Blue Cross Blue Shield of Michigan
- CMS Medicare
- +2 more carriersWith a free account
Plan types Dr. Alderuccio accepts, by number of carriers
- PPO6
- Medicare5
- HMO4
- POS4
- EPO3
Source: Dmand AI Insurance Network Data
Sources for Dr. Juan Pablo Alderuccio's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Juan Pablo Alderuccio
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Juan Pablo Alderuccio's NPI number?
Dr. Juan Pablo Alderuccio's NPI number is 1639502123. It was assigned on August 20, 2013, and it is active in the NPI Registry.
What kind of doctor is Dr. Juan Pablo Alderuccio?
Dr. Juan Pablo Alderuccio is a hematologist and oncologist in Miami, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Juan Pablo Alderuccio practice?
Dr. Alderuccio practices at 1475 Nw 12th Ave, Miami, FL 33136. Dr. Alderuccio's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.
What is Dr. Juan Pablo Alderuccio's medical license number?
Dr. Alderuccio holds Florida license ME131937.
Which hospitals is Dr. Juan Pablo Alderuccio affiliated with?
Dr. Alderuccio practices at Sylvester Comprehensive Cancer Center in Miami, Florida. Dr. Alderuccio is also affiliated with Jackson Memorial Hospital.
What medical group is Dr. Juan Pablo Alderuccio part of?
Dr. Alderuccio is linked to University of Miami Health System.
Does Dr. Juan Pablo Alderuccio accept Medicare?
Yes. CMS data shows Dr. Alderuccio billed Medicare for 266 services in 2024, and Dr. Alderuccio accepts Medicare assignment.
Does Dr. Juan Pablo Alderuccio offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Alderuccio as offering telehealth services.
What is Dr. Juan Pablo Alderuccio's MIPS score?
Dr. Alderuccio's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.
How many Medicare patients does Dr. Juan Pablo Alderuccio see?
CMS counts 105 Medicare patients who saw Dr. Alderuccio in 2024, with an average age of 73.
Show 8 more questionsShow fewer questions
Is Dr. Juan Pablo Alderuccio board certified?
Yes. Dr. Alderuccio is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Juan Pablo Alderuccio bill to Medicare?
In 2024, Dr. Alderuccio's most billed Medicare services were office visit, established patient (99214), hospital inpatient care (99233) and office visit, established patient (99215).
What drugs does Dr. Juan Pablo Alderuccio prescribe most?
In 2024 Medicare Part D data, Dr. Alderuccio's most prescribed drugs by claims were Acyclovir, Entecavir and Prednisone.
Has Dr. Juan Pablo Alderuccio received payments from drug or device companies?
CMS Open Payments shows $50,498 in general payments to Dr. Alderuccio from 26 companies from 2016 to 2025. The largest total came from ADC Therapeutics America, Inc.
How long has Dr. Juan Pablo Alderuccio been practicing?
Dr. Alderuccio graduated from medical school in 2003, 23 years ago.
Does Dr. Juan Pablo Alderuccio do research?
Dmand AI links 72 publications to Dr. Alderuccio, published from 2013 to 2025. Dr. Alderuccio has worked on 3 clinical trials.
Who does Dr. Juan Pablo Alderuccio publish with?
Dr. Alderuccio's most frequent co-authors are Izidore Lossos, MD (49 shared papers), Paolo F. Caimi, MD (12 shared papers) and Brad Steven Kahl, MD (12 shared papers).
What insurance does Dr. Juan Pablo Alderuccio accept?
Dr. Alderuccio is in network with 10 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card